Literature DB >> 24015859

The internet administration version of the 20-item Toronto alexithymia scale.

R Michael Bagby1, Lindsay E Ayearst2, Raluca A Morariu2, Carolyn Watters3, Graeme J Taylor4.   

Abstract

Researchers are increasingly administering tests developed and validated in paper format via the Internet. Yet, the equivalence between paper and Internet concerning administration of tests is not typically demonstrated. We evaluated the reliability, factorial and external validity, and measurement equivalency of the Internet version of the 20-item Toronto Alexithymia Scale (TAS-20; Bagby, Parker, & Taylor, 1994; Bagby, Taylor, & Parker, 1994; Lumley et al., 2007) vis-à-vis the paper version. Participants (N = 621) completed the TAS-20 either on the Internet or on paper. Reliability and item-to-scale homogeneity were evaluated for each format. We used confirmatory factor analyses (CFAs) to evaluate factorial validity and used CFA-based factorial invariance procedures to determine measurement equivalency. Alpha coefficients and mean interitem correlations (MICs) were adequate for the full-scale TAS-20 Internet and paper versions and the difficulty identifying feelings (DIF) and difficulty describing feelings (DDF) factor scale test scores; in both formats, alpha and MICs were poorer for externally oriented thinking (EOT) factor test scores compared to scores for the DIF and DDF. The fit of the 3-factor structure of the TAS-20 was adequate for both formats. Factorial invariance across formats was also demonstrated; mean scores for the total scale and each factor scale were not different across formats. Correlations with the domain and facet scales of the Revised NEO Personality Inventory (Costa & McCrae, 1992b) were mostly similar across formats. The Internet and paper versions of the TAS-20 are comparably reliable and valid. An Internet version of the TAS-20 expands opportunities to collect data and permits generalizing of results across studies using the different modes of administration. 2014 APA

Entities:  

Mesh:

Year:  2013        PMID: 24015859     DOI: 10.1037/a0034316

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  8 in total

1.  The Interoception Sensory Questionnaire (ISQ): A Scale to Measure Interoceptive Challenges in Adults.

Authors:  L Fiene; M J Ireland; C Brownlow
Journal:  J Autism Dev Disord       Date:  2018-10

2.  Mood Disorders in High-Functioning Autism: The Importance of Alexithymia and Emotional Regulation.

Authors:  Kristen P Morie; Scott Jackson; Zu Wei Zhai; Marc N Potenza; Barbara Dritschel
Journal:  J Autism Dev Disord       Date:  2019-07

3.  Enhancing the Validity of a Quality of Life Measure for Autistic People.

Authors:  Helen McConachie; David Mason; Jeremy R Parr; Deborah Garland; Colin Wilson; Jacqui Rodgers
Journal:  J Autism Dev Disord       Date:  2018-05

4.  Are Autistic and Alexithymic Traits Distinct? A Factor-Analytic and Network Approach.

Authors:  Hélio Clemente Cuve; Jennifer Murphy; Hannah Hobson; Eri Ichijo; Caroline Catmur; Geoffrey Bird
Journal:  J Autism Dev Disord       Date:  2021-06-01

5.  Engagement in dance is associated with emotional competence in interplay with others.

Authors:  Eva Bojner Horwitz; Anna-Karin Lennartsson; Töres P G Theorell; Fredrik Ullén
Journal:  Front Psychol       Date:  2015-07-31

6.  Musical activity and emotional competence - a twin study.

Authors:  Töres P Theorell; Anna-Karin Lennartsson; Miriam A Mosing; Fredrik Ullén
Journal:  Front Psychol       Date:  2014-07-16

7.  Psychometric Properties of the Bermond-Vorst Alexithymia Questionnaire (BVAQ) in the General Population and a Clinical Population.

Authors:  Lars de Vroege; Wilco H M Emons; Klaas Sijtsma; Christina M van der Feltz-Cornelis
Journal:  Front Psychiatry       Date:  2018-04-23       Impact factor: 4.157

8.  An Ontology-Based Framework for Psychological Monitoring in Education During the COVID-19 Pandemic.

Authors:  Alia El Bolock; Slim Abdennadher; Cornelia Herbert
Journal:  Front Psychol       Date:  2021-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.